glp 1 glucagon receptor pathway Glucagon-like Peptide-1 (GLP-1R) Signaling: Making the Case for a Functionally Gs Protein-Selective GPCR Glucagon‐like peptide‐1: Are its roles

Disclosures Jos Luis Grriz has served as consultant to Boehringer Ingelheim, Mundipharma, AstraZeneca, and Novo Nordisk and has received speaker honoraria from Boehringer Ingelheim, Mundipharma, AstraZeneca, Novo Nordisk, Novartis, and Eli Lilly and Company

Takaaki Kanemaru (Department of Morphology Core Unit, Kyushu University Hospital) and The Research Support Center, Research Center for Human Disease Modeling, Kyushu University Graduate School of Medical Sciences, which is partially supported by the Mitsuaki Shiraishi Fund for Basic Medical Research

"The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum"

endocrine-abstracts.org Better lipid profiles, reduced visceral adipose tissue: Low testosterone is linked with visceral fat accumulation (which drives metabolic risk)